23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition by Glenn S. Demby | Jul 11, 2021 | Articles, Deals-lir, Featured, Laboratory Industry Report...This content is for Paid Members only.Login Register
PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting by Glenn S. Demby | Jun 14, 2021 | Articles, Deals-lir, Featured, Laboratory Industry Report...This content is for Paid Members only.Login Register
Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making by Glenn S. Demby | May 19, 2021 | Articles, Deals-lir, Laboratory Industry Report...This content is for Paid Members only.Login Register
Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse by Glenn S. Demby | May 6, 2021 | Articles, Deals-lir, Laboratory Industry Report...This content is for Paid Members only.Login Register
M&A Report: Roche Merges with GenMark Diagnostics to Create Syndromic Testing Powerhouse by Glenn S. Demby | Apr 22, 2021 | Articles, Deals-lir, Laboratory Industry Report...This content is for Paid Members only.Login Register